{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:05:55Z","timestamp":1790805955882,"version":"4.1.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamacardio.2018.2866","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T03:41:06Z","timestamp":1539747666000},"page":"957","source":"Crossref","is-referenced-by-count":72,"title":["Association of Genetically Enhanced Lipoprotein Lipase\u2013Mediated Lipolysis and Low-Density Lipoprotein Cholesterol\u2013Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes"],"prefix":"10.1001","volume":"3","author":[{"given":"Luca A.","family":"Lotta","sequence":"first","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel D.","family":"Stewart","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Sharp","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix R.","family":"Day","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[{"name":"MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom"},{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian\u2019an","family":"Luan","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bowker","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Cai","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B. L.","family":"Wittemans","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola D.","family":"Kerrison","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom"},{"name":"Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"O\u2019Rahilly","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Scott","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Savage","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R. B.","family":"Perry","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Langenberg","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Wareham","sequence":"additional","affiliation":[{"name":"MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"16","key":"hoi180042r1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1056\/NEJM198904203201607","article-title":"Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases.","volume":"320","author":"Eckel","year":"1989","journal-title":"N Engl J Med"},{"issue":"12","key":"hoi180042r2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease.","volume":"374","author":"Stitziel","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"hoi180042r3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/aje\/kwn235","article-title":"Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis.","volume":"168","author":"Sagoo","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"23","key":"hoi180042r4","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"hoi180042r5","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease.","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi180042r6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease.","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"hoi180042r7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease.","volume":"374","author":"Dewey","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi180042r8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi180042r9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease.","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"hoi180042r10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/jama.2017.0972","article-title":"Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease.","volume":"317","author":"Khera","year":"2017","journal-title":"JAMA"},{"issue":"7537","key":"hoi180042r11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"issue":"1","key":"hoi180042r12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"issue":"2","key":"hoi180042r13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/(ISSN)1099-0895","article-title":"Lipoprotein lipase in diabetes.","volume":"3","author":"Taskinen","year":"1987","journal-title":"Diabetes Metab Rev"},{"issue":"12","key":"hoi180042r14","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals.","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"hoi180042r15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41588-018-0084-1","article-title":"Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes.","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"issue":"2","key":"hoi180042r16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.bbrc.2014.06.114","article-title":"Identification of a small molecule that stabilizes lipoprotein lipase in vitro and lowers triglycerides in vivo.","volume":"450","author":"Larsson","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"hoi180042r17","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.bmcl.2014.03.021","article-title":"A novel lipoprotein lipase (LPL) agonist rescues the enzyme from inhibition by angiopoietin-like 4 (ANGPTL4).","volume":"24","author":"Geldenhuys","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"23","key":"hoi180042r18","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome.","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi180042r19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia.","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi180042r20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1056\/NEJMoa1701329","article-title":"Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides.","volume":"377","author":"Graham","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi180042r21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJMc1705994","article-title":"ANGPTL3 inhibition in homozygous familial hypercholesterolemia.","volume":"377","author":"Gaudet","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"hoi180042r22","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","article-title":"Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase.","volume":"67","author":"W\u00fcrtz","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"hoi180042r23","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"hoi180042r24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S2213-8587(16)00003-6","article-title":"Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data.","volume":"4","author":"Sattar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"16","key":"hoi180042r25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","article-title":"Cardiovascular efficacy and safety of bococizumab in high-risk patients.","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"15","key":"hoi180042r26","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol.","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"hoi180042r27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/dom.12909","article-title":"Lipid-lowering efficacy and safety of alirocumab in patients with or without diabetes: a sub-analysis of ODYSSEY COMBO II.","volume":"19","author":"Leiter","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"hoi180042r28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications.","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"issue":"8","key":"hoi180042r29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","article-title":"Validating therapeutic targets through human genetics.","volume":"12","author":"Plenge","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"hoi180042r30","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s00125-011-2182-9","article-title":"Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study.","volume":"54","author":"Langenberg","year":"2011","journal-title":"Diabetologia"},{"key":"hoi180042r31","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort: European Prospective Investigation of Cancer.","volume":"80","author":"Day","year":"1999","journal-title":"Br J Cancer"},{"issue":"3","key":"hoi180042r32","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"10","key":"hoi180042r33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes\u2013based genome-wide association meta-analysis of coronary artery disease.","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"hoi180042r34","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes.","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"issue":"7538","key":"hoi180042r35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology.","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"issue":"7538","key":"hoi180042r36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14132","article-title":"New genetic loci link adipose and insulin biology to body fat distribution.","volume":"518","author":"Shungin","year":"2015","journal-title":"Nature"},{"issue":"9","key":"hoi180042r37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways.","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"hoi180042r38","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"issue":"11","key":"hoi180042r39","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"hoi180042r40","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","article-title":"The EPIC Project: rationale and study design: European Prospective Investigation Into Cancer and Nutrition.","volume":"26","author":"Riboli","year":"1997","journal-title":"Int J Epidemiol"},{"issue":"7499","key":"hoi180042r41","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","article-title":"What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?","volume":"330","author":"Davey Smith","year":"2005","journal-title":"BMJ"},{"issue":"15","key":"hoi180042r42","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial mendelian randomization study.","volume":"65","author":"Ference","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"hoi180042r43","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes.","volume":"375","author":"Ference","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"hoi180042r44","doi-asserted-by":"publisher","first-page":"13213","DOI":"10.1074\/jbc.M900553200","article-title":"Genetic variation in ANGPTL4 provides insights into protein processing and function.","volume":"284","author":"Yin","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"hoi180042r45","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes.","volume":"9","author":"Gusarova","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"hoi180042r46","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis.","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"issue":"25","key":"hoi180042r47","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1056\/NEJMe1507041","article-title":"Proof that lower is better\u2014LDL cholesterol and IMPROVE-IT.","volume":"372","author":"Jarcho","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"hoi180042r48","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.v35.11","article-title":"Combining information on multiple instrumental variables in mendelian randomization: comparison of allele score and summarized data methods.","volume":"35","author":"Burgess","year":"2016","journal-title":"Stat Med"},{"issue":"21","key":"hoi180042r49","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants.","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"issue":"6","key":"hoi180042r50","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes.","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"10","key":"hoi180042r51","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2337\/db10-0678","article-title":"Femoral adipose tissue may accumulate the fat that has been recycled as VLDL and nonesterified fatty acids.","volume":"59","author":"McQuaid","year":"2010","journal-title":"Diabetes"},{"issue":"7","key":"hoi180042r52","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.2337\/db14-1710","article-title":"Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes.","volume":"64","author":"Fall","year":"2015","journal-title":"Diabetes"},{"issue":"13","key":"hoi180042r53","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis.","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"hoi180042r54","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"issue":"9965","key":"hoi180042r55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"hoi180042r56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease.","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"issue":"9841","key":"hoi180042r57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"issue":"25","key":"hoi180042r58","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a mendelian randomization analysis.","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/edhub.ama-assn.org\/journals\/jamacardiology\/fullarticle\/2702977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T06:30:47Z","timestamp":1539844247000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiology.jamanetwork.com\/article.aspx?doi=10.1001\/jamacardio.2018.2866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2018.2866","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}